J0570 — Buprenorphine implant, 74.2 mg
J0570 is a HCPCS Level II code for buprenorphine implant, 74.2 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J0570
- Long descriptor
- Buprenorphine implant, 74.2 mg
- Short descriptor
- Buprenorphine implant 74.2mg
- Added
- January 1, 2017
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0570
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0570 is not quite right, the correct code is very often within a few positions of it.
- J0517Injection, benralizumab, 1 mg
- J0520Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
- J0525Injection, cefotetan disodium, 10 mg
- J0528Injection, fosfomycin disodium, 20 mg
- J0558Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
- J0561Injection, penicillin g benzathine, 100,000 units
- J0565Injection, bezlotoxumab, 10 mg
- J0567Injection, cerliponase alfa, 1 mg
- J0571Buprenorphine, oral, 1 mg
- J0572Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
- J0573Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
- J0574Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
- J0575Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
- J0576Injection, buprenorphine extended-release (brixadi), 1 mgterminated
- J0577Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
- J0578Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
Questions about J0570
What is HCPCS code J0570?
J0570 is a HCPCS Level II code for buprenorphine implant, 74.2 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0570?
The CMS HCPCS file marks J0570 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J0570 paid under the physician fee schedule?
J0570 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).